Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2576-2588

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brude, I. R.
Right arrow Articles by Nenseter, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brude, I. R.
Right arrow Articles by Nenseter, M. S.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2576-2588.)
© 1997 American Heart Association, Inc.


Articles

Peroxidation of LDL From Combined-Hyperlipidemic Male Smokers Supplied With ¯-3 Fatty Acids and Antioxidants

Ingeborg R. Brude; Christian A. Drevon; Ingvar Hjermann; Ingebjørg Seljeflot; Sissel Lund-Katz; Kristin Saarem; Berit Sandstad; Kari Solvoll; Bente Halvorsen; Harald Arnesen; ; Marit S. Nenseter

From the Institute for Nutrition Research, University of Oslo (I.R.B, C.A.D, B.S, K.S, B.H, M.S.N), Ullevål University Hospital (I.H, I.S, H.A), Petter Möller Orkla ASA (K.S), Oslo, Norway, and Allegheny University of the Health Sciences, MCP Hahnemann School of Medicine (S.L.K), Philadelphia, Pa.

Correspondence to Marit S. Nenseter, Institute for Nutrition Research, University of Oslo, Songsvannsvn. 9, 0450 Oslo, Norway. E-mail marit.nenseter{at}basalmed.uio.no

Abstract The effects of marine ¯-3 polyunsaturated fatty acids (FAs) and antioxidants on the oxidative modification of LDL were studied in a randomized, double-blind, placebo-controlled trial. Male smokers (n=41) with combined hyperlipidemia were allocated to one of four groups receiving supplementation with ¯-3 FAs (5 g eicosapentaenoic acid and docosahexaenoic acid per day), antioxidants (75 mg vitamin E, 150 mg vitamin C, 15 mg ß-carotene, and 30 mg coenzyme Q10 per day), both ¯-3 FAs and antioxidants, or control oils. LDL and human mononuclear cells were isolated from the patients at baseline and after 6 weeks of supplementation. LDL was subjected to cell-mediated oxidation by the patients' own mononuclear cells, as well as to Cu2+-catalyzed and 2,2'-azobis-(2-amidinopropane hydrochloride) (AAPH)–initiated oxidation. Extent of LDL modification was measured as lag time, the formation rate of conjugated dienes (CDs), the maximum amount of CDs formed, formation of lipid peroxides, and the relative electrophoretic mobility of LDL on agarose gels. Dietary supplementation with ¯-3 FAs increased the concentration of total ¯-3 FAs in LDL and reduced the concentration of vitamin E in serum. The ¯-3 FA–enriched LDL particles were not more susceptible to Cu2+-catalyzed, AAPH-initiated, or autologous cell–mediated oxidation than control LDL. In fact, enrichment with ¯-3 FAs significantly reduced the formation rate of CDs when LDL was subjected to AAPH-induced oxidation. Supplementation with moderate amounts of antioxidants significantly increased the concentration of vitamin E in serum and increased the resistance of LDL to undergo Cu2+-catalyzed oxidation, measured as increased lag time, reduced formation of lipid peroxides, and reduced relative electrophoretic mobility compared with control LDL. Supplementation with ¯-3 FAs/antioxidants showed oxidizability of LDL similar to that of control LDL and ¯-3 FA–enriched LDL. In conclusion, ¯-3 FAs neither rendered the LDL particles more susceptible to undergo in vitro oxidation nor influenced mononuclear cells' ability to oxidize autologous LDL, whereas moderate amounts of antioxidants protected LDL against oxidative modification.


Key Words: antioxidants • human mononuclear cells • hyperlipidemia • oxidized LDL • ¯-3 fatty acids




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. B. Holven, J. K. Damas, A. Yndestad, T. Waehre, T. Ueland, B. Halvorsen, L. Heggelund, W. J. Sandberg, A. G. Semb, S. S. Froland, et al.
Chemokines in Children With Heterozygous Familiar Hypercholesterolemia: Selective Upregulation of RANTES
Arterioscler Thromb Vasc Biol, January 1, 2006; 26(1): 200 - 205.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. B. Holven, A. M. Myhre, P. Aukrust, T. A. Hagve, L. Ose, and M. S. Nenseter
Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo: Dependency of xanthomas/xanthelasms, smoking and gender
Eur. Heart J., October 1, 2003; 24(19): 1756 - 1762.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Y. V. Yuan and D. D. Kitts
Dietary (n-3) Fat and Cholesterol Alter Tissue Antioxidant Enzymes and Susceptibility to Oxidation in SHR and WKY Rats
J. Nutr., March 1, 2003; 133(3): 679 - 688.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. M. Kris-Etherton, W. S. Harris, L. J. Appel, and for the Nutrition Committee
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): e20 - 30.
[Full Text] [PDF]


Home page
CirculationHome page
P. M. Kris-Etherton, W. S. Harris, L. J. Appel, and for the Nutrition Committee
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Circulation, November 19, 2002; 106(21): 2747 - 2757.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. B. Holven, P. Aukrust, T. Holm, L. Ose, and M. S. Nenseter
Folic Acid Treatment Reduces Chemokine Release From Peripheral Blood Mononuclear Cells in Hyperhomocysteinemic Subjects
Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 699 - 703.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. B. Weinberg, B. S. VanderWerken, R. A. Anderson, J. E. Stegner, and M. J. Thomas
Pro-Oxidant Effect of Vitamin E in Cigarette Smokers Consuming a High Polyunsaturated Fat Diet
Arterioscler Thromb Vasc Biol, June 1, 2001; 21(6): 1029 - 1033.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. E. Reseland, F. Haugen, K. Hollung, K. Solvoll, B. Halvorsen, I. R. Brude, M. S. Nenseter, E. N. Christiansen, and C. A. Drevon
Reduction of leptin gene expression by dietary polyunsaturated fatty acids
J. Lipid Res., May 1, 2001; 42(5): 743 - 750.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
J. V. Higdon, S. H. Du, Y. S. Lee, T. Wu, and R. C. Wander
Supplementation of postmenopausal women with fish oil does not increase overall oxidation of LDL ex vivo compared to dietary oils rich in oleate and linoleate
J. Lipid Res., March 1, 2001; 42(3): 407 - 418.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
O. Johansen, I. Seljeflot, A. T. Hostmark, and H. Arnesen
The Effect of Supplementation With Omega-3 Fatty Acids on Soluble Markers of Endothelial Function in Patients With Coronary Heart Disease
Arterioscler Thromb Vasc Biol, July 1, 1999; 19(7): 1681 - 1686.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. B. Holven, P. Aukrust, T. Holm, L. Ose, and M. S. Nenseter
Folic Acid Treatment Reduces Chemokine Release From Peripheral Blood Mononuclear Cells in Hyperhomocysteinemic Subjects
Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 699 - 703.
[Abstract] [Full Text] [PDF]